(-0.11%) 5 463.03 points
(-0.08%) 39 080 points
(0.12%) 17 738 points
(-0.63%) $80.32
(-4.32%) $2.64
(-0.79%) $2 312.40
(0.13%) $28.91
(2.33%) $1 009.40
(0.27%) $0.936
(0.72%) $10.68
(0.48%) $0.792
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States...
Stats | |
---|---|
Today's Volume | 31 317 |
Average Volume | 0 |
Market Cap | 7.08M |
EPS | $-0.430 ( Q2 | 2022-08-12 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.60 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.366 (15.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Hardy Reginald L | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Samant Vijay B | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
2022-05-17 | Lyons Gary A | Buy | 65 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 10 056 470 | Sell: 193 721 |
Volume Correlation
Brickell Biotech, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Brickell Biotech, Inc. Correlation - Currency/Commodity
Brickell Biotech, Inc. Financials
Annual | 2021 |
Revenue: | $404 000 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2021 |
Revenue: | $404 000 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-22.05 |
FY | 2020 |
Revenue: | $1.82M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-38.25 |
FY | 2019 |
Revenue: | $7.92M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-202.50 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Brickell Biotech, Inc.
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators